Condensed Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 5,880,861	$ 12,077,640
Prepaid expenses and other current assets	475,005	807,356
Total current assets	6,355,866	12,884,996
Property and equipment, net	158,555	193,974
Other assets:
Goodwill	7,647,267	7,647,267
In-process research and development	118,600	118,600
Other non-current assets	510,941	620,674
Total assets	14,791,229	21,465,511
Current liabilities:
Accounts payable	434,466	561,090
Accrued expenses	2,082,981	1,944,431
Other current liabilities	530,054	263,392
Total current liabilities	3,047,501	2,768,913
Other non-current liabilities	525,357	326,282
Total liabilities	3,572,858	3,095,195
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 10,612,731 and 10,095,176 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively	1,062	1,010
Additional paid-in capital	98,187,329	94,619,818
Accumulated deficit	(86,970,020)	(76,250,512)
Total stockholders’ equity	11,218,371	18,370,316
Total liabilities and stockholders’ equity	$ 14,791,229	$ 21,465,511